InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Jafri Hasan, Directeur Médical. Officer active across 1 companies, notably Aridis Pharmaceuticals, Inc.. Cumulatively, 2 filings have been recorded. Total volume traded: €21k. The latest transaction was disclosed on 3 September 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations2 total
€10,5143,009 shares@ €3.4943100.0% of flow
Common Stock
SEC:0001104659-21-113792·
Ideal exit: 31 May 2022 (T+270)
€10,5143,009 shares@ €3.49430.034% mcap50.0% of flow
Common Stock
SEC:0001104659-21-113792:0·
Ideal exit: 31 May 2022 (T+270)
2 of 2 declarations
About Jafri Hasan
Hasan Jafri serves as the Chief Medical Officer at Aridis Pharmaceuticals, Inc. In this role, he is responsible for leading the company's medical and clinical initiatives, which focus on developing innovative treatments for infectious diseases. Hasan plays a crucial role in Aridis's research and development strategy, contributing to the advancement of therapeutic solutions. His medical expertise is essential for the company's success.
